S. Pavletic

发表

Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.

H. Atkins, K. Sullivan, M. Pasquini, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?

H. Atkins, J. V. van Laar, P. Muraro, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HSCT for AID: entering prime time?

S. Pavletic, 2011, Blood.

Amniotic membrane transplantation—a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease

D. Pulanić, S. Pavletic, Z. Perić, 2018, Bone Marrow Transplantation.

Extracorporeal photopheresis as a therapy for autoimmune diseases

D. Stroncek, S. Pavletic, Z. Kuzmina, 2015, Journal of clinical apheresis.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

M. Turner, J. Wingard, Stephanie J. Lee, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic graft versus host disease

K. Baird, S. Pavletic, 2006, Current opinion in hematology.

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

James Ferrara, Peter A Lachenbruch, Daniel Couriel, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.

A. Barrett, G. Hoehn, M. Bishop, 2007, Experimental hematology.

Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD

H. Greinix, M. Gosau, S. Elad, 2011, Clinical Oral Investigations.

Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia

G. Illei, J. Cohen, J. Gea-Banacloche, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

Oral Disease Profiles in Chronic Graft versus Host Disease

S. Steinberg, K. Baird, M. Datiles, 2015, Journal of dental research.

Malnutrition in patients with chronic GVHD

S. Steinberg, K. Baird, S. Mitchell, 2014, Bone Marrow Transplantation.

NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD

S. Steinberg, A. Berger, S. Mitchell, 2014, Bone Marrow Transplantation.

Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures

S. Steinberg, K. Baird, S. Mitchell, 2014, Bone Marrow Transplantation.

Oral Chronic Graft-vs.-Host Disease Characterization Using the NIH Scale

S. Steinberg, K. Baird, S. Mitchell, 2012, Journal of dental research.

Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.

M. Mayes, B. Sandmaier, Roland Martin, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation.

M. Mohty, Shaji K. Kumar, M. Pasquini, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.

S. Pavletic, C. Bassim, H. Fassil, 2013, Oral diseases.

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

G. Kraft, K. Sullivan, R. Storb, 2003, Blood.

Hepatic Complications of Hematopoietic Stem Cell Transplantation

S. Pavletic, T. Heller, N. Samala, 2013 .

Utilization of Chimeric Antigen Receptor (CAR) T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B cell non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

M. Bar, F. Awan, D. Miklos, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus

G. Illei, D. Farge, T. Martin, 2011, Annals of the rheumatic diseases.

Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.

Thomas E. Hughes, W. Wilson, S. Steinberg, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeted pretransplant host lymphocyte depletion prior to T‐cell depleted reduced‐intensity allogeneic stem cell transplantation

S. Steinberg, M. Bishop, J. Gea-Banacloche, 2004, British journal of haematology.

Consensus Grading for Cytokine Release Syndrome and Neurologic D 224 X X Toxicity Associated with Immune Effector Cells

S. Grupp, J. Dipersio, K. Peggs, 2019 .

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.

S. Grupp, J. Dipersio, M. V. D. van den Brink, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)

M. Bar, G. Mufti, S. Grupp, 2019, Bone Marrow Transplantation.

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.

M. Bar, G. Mufti, S. Grupp, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of Hematologic Malignancy Relapse in Patients with Advanced Chronic Graft-versus-Host Disease

S. Steinberg, A. Berger, S. Mitchell, 2021, Bone Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.

J. Ritz, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Challenges in Conducting Studies in Chronic Graft-versus-Host Disease

S. Pavletic, I. Pusic, 2019, Clinical hematology international.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

H. Greinix, Stephanie J. Lee, M. Flowers, 2015 .

disease: a multicenter study Performance of a new clinical grading system for chronic graft-versus-host

J. Lynch, M. Horowitz, Stephanie J. Lee, 2013 .

Are we making progress in GVHD prophylaxis and treatment?

S. Pavletic, D. Fowler, 2012, Hematology. American Society of Hematology. Education Program.

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Blood.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

E. Holler, H. Greinix, A. Kiani, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Biology and management of chronic graft-versus-host disease.

Paul J. Martin, S. Pavletic, P. Martin, 2009, Cancer treatment and research.

Chronic Graft-versus-Host Disease - Clinical Manifestations and Therapy

M. Flowers, S. Pavletic, P. Carpenter, 2009 .

Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.

Stephanie J. Lee, Paul J. Martin, L. M. Griffith, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation's greatest challenges: advances in chronic graft-versus-host disease.

Stephanie J. Lee, D. Couriel, S. Pavletic, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic factors of chronic graft‐versus‐host disease after allogeneic blood stem‐cell transplantation

J. Armitage, Lynette M. Smith, P. Bierman, 2005, American journal of hematology.

Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study.

J. Lynch, S. Piantadosi, M. Horowitz, 2003, Blood.

National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.

N. Kröger, D. Porter, C. June, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation for chronic lymphocytic leukemia: potential cure for an incurable disease

K. Foon, M. Boyiadzis, S. Pavletic, 2007, Expert opinion on biological therapy.

Introduction to a review series on emerging immunotherapies for hematologic diseases.

C. Bollard, S. Paczesny, S. Pavletic, 2018, Blood.

National Institutes of Health (NIH) Chronic GVHD Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis

J. Shelhamer, J. Gea-Banacloche, K. Baird, 2013 .

Oral Complications of Chronic Graft-Versus-Host Disease.

S. Pavletic, M. Schubert, J. Mays, 2019, Journal of the National Cancer Institute. Monographs.

Meaningful response criteria for myelodysplastic syndromes

S. Pavletic, K. Norsworthy, Nina Kim, 2021, British journal of haematology.

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Alan M. Miller, R. Vij, W. Wood, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acupuncture treatment for persistent hiccups in patients with cancer.

G. Giaccone, M. Hughes, S. Pavletic, 2010, Journal of alternative and complementary medicine.

Towards a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

B. Banas, G. Cuvelier, W. Kimberly, 2022, Transplantation and cellular therapy.

Vulvovaginal Chronic Graft-Versus-Host Disease With Allogeneic Hematopoietic Stem Cell Transplantation

M. Turner, M. Bishop, R. Childs, 2007, Obstetrics and gynecology.

Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease

S. Steinberg, A. Im, K. Baird, 2022, HemaSphere.

Spiritual Well-Being in Long-Term Survivors with Chronic Graft versus Host Disease after Hematopoietic Stem Cell Transplant (HSCT)

S. Steinberg, S. Mitchell, S. Pavletic, 2012 .

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

K. Washington, T. Morton, D. Kleiner, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

M. Washington, Z. Argényi, A. Rashid, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation

Sadik H. Kassim, W. Telford, S. Rosenberg, 2013 .

Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study

F. Ferris, R. Childs, J. Barrett, 2021, Bone Marrow Transplantation.

Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.

S. Steinberg, B. Levine, C. June, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of immune ablation and stem cell transplantation in severe SLE.

G. Illei, S. Pavletic, 2005, Best practice & research. Clinical rheumatology.

Blood stem cells as therapy for severe lupus

G. Illei, S. Pavletic, 2005, Expert opinion on biological therapy.

Allogeneic Hematopoietic Stem Cell Transplantation: Does It Have a Place in Treating Hodgkin Lymphoma?

M. Bishop, S. Pavletic, R. Salit, 2010, Current hematologic malignancy reports.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms

D. Kleiner, S. Bhatia, E. Engels, 2017 .

Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.

M. Pučić-Baković, M. Pezer, D. Pulanić, 2016, Biochimica et biophysica acta.

Hepatic Complications

C. Koh, S. Pavletic, T. Heller, 2022, Blood and Marrow Transplantation Long Term Management.

Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study

M. Pučić-Baković, G. Lauc, D. Pulanić, 2021, Frontiers in Immunology.

granulocyte colony-stimulating factor: association with donor characteristics Decreased immune functions of blood cells following mobilization with

J. Lynch, M. Bishop, S. Joshi, 2013 .

Thrombocytopenia and hemostatic disorders in chronic graft versus host disease

D. Pulanić, S. Pavletic, J. Lozier, 2009, Bone Marrow Transplantation.

Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.

A. Barrett, M. Bishop, R. Childs, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.

G. Illei, A. Barrett, M. Bishop, 2004, Blood.

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

R. Vij, D. Lad, M. Perales, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A new standard in GVHD prophylaxis? An introduction to BMT CTN 1703.

W. Wood, Bryce Waldman, Z. DeFilipp, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE 2014 NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. Pathology Working Group Report

M. Washington, Z. Argényi, A. Rashid, 2006 .

ORIGINAL ARTICLE Genetically identical twin transplantation for chronic lymphocytic leukemia

G. Marti, W. Chan, E. Montserrat, 2007 .

Genetically identical twin transplantation for chronic lymphocytic leukemia

G. Marti, W. Chan, E. Montserrat, 2007, Leukemia.

Novel targets in the treatment of chronic graft-versus-host disease

A. Im, S. Pavletic, F. Hakim, 2017, Leukemia.

Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-versus-Host Disease Studies.

Stephanie J. Lee, B. Blazar, S. Pavletic, 2022, Transplantation and cellular therapy.

Clinical characteristics and cytokine biomarkers in patients with chronic graft‐vs‐host disease persisting seven or more years after diagnosis

S. Steinberg, A. Im, E. Cowen, 2020, American journal of hematology.

Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients

S. Steinberg, J. Zolton, K. Baird, 2018, Bone Marrow Transplantation.

FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation

J. Pidala, Stephanie J. Lee, M. Flowers, 2016 .

Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pulmonary symptoms measured by the NIH Lung score predict overall survival, non-relapse mortality and patient-reported outcomes in chronic GVHD

W. Wood, B. Kurland, J. Pidala, 2014 .

Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

W. Wood, B. Kurland, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prevalence of Isolated Joint Involvement in Chronic Graft‐Versus‐Host Disease: Comment on the Article by Inamoto et al

S. Steinberg, K. Baird, E. Cowen, 2014, Arthritis & rheumatology.

Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.

D. Kleiner, S. Mitchell, J. Atkinson, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation.

J. Armitage, M. Grever, J. Byrd, 2003, Transplantation.

Gastrointestinal complications

S. Pavletic, T. Heller, S. Bhattacharya, 2022, Blood and Marrow Transplantation Long Term Management.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease.

M. Lodish, K. Baird, N. Sinaii, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

M. Bar, G. Mufti, S. Grupp, 2021 .

Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy.

S. Steinberg, M. Bishop, D. Danforth, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparative analysis of FoxP3+ regulatory T cells in the target tissues and blood in chronic graft versus host disease

W. Swaim, E. Cowen, S. Pavletic, 2014, Leukemia.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.

J. Pidala, H. Greinix, V. Bhatt, 2021, Transplantation and cellular therapy.

Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease

S. Pavletic, N. Nikolov, 2008, Nature Clinical Practice Rheumatology.

Biomarkers for Chronic Graft-versus-Host isease : National Institutes of Health Consensus evelopment Project on Criteria for Clinical Trials n Chronic Graft-versus-Host Disease : III . Biomarker orking Group Report

P. Lachenbruch, D. Miklos, E. Holler, 2006 .

Prospective phase II trial of montelukast to treat bronchiolitis obliterans syndrome after hematopoietic cell transplant and investigation into BOS pathogenesis.

S. Steinberg, Stephanie J. Lee, J. Gea-Banacloche, 2022, Transplantation and cellular therapy.

Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.

S. Pavletic, J. Chien, S. Duncan, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa.

W. Swaim, S. Pavletic, R. Gress, 2009, Blood.

ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006 .

Metabolic reprogramming augments potency of human pSTAT3-inhibited iTregs to suppress alloreactivity.

J. Cleveland, S. Sebti, J. Pidala, 2020, JCI insight.

Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation

S. Pavletic, N. P. Buxbaum, 2020, Frontiers in Immunology.

High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation.

S. Pavletic, R. Nash, P. Gwilt, 2003, International immunopharmacology.

Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.

S. Pavletic, V. Ratanatharathorn, J. Uberti, 2009, Cancer treatment reviews.

Haematopoietic stem cell transplantation: indications, clinical developments and future directions

M. Boyiadzis, S. Pavletic, 2004, Expert opinion on pharmacotherapy.

EBMT—NIH—CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

E. Holler, H. Greinix, Stephanie J. Lee, 2018, Bone Marrow Transplantation.

Biomarkers in chronic graft-versus-host disease: quo vadis?

E. Weissinger, E. Holler, J. Hansen, 2018, Bone Marrow Transplantation.

Chronic graft-vs-host disease in 2016: a major challenge and an opportunity

H. Greinix, D. Pulanić, S. Pavletic, 2016, Croatian medical journal.

2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series.

Stephanie J. Lee, S. Pavletic, G. Vogelsang, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE: NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. The 2014 Pathology Working Group Report

T. Morton, D. Kleiner, J. Greenson, 2015 .

Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic graft-versus-host disease: An international survey of the EBMT-NCI Chronic GVHD Task Force

J. Madrigal, H. Greinix, Stephanie J. Lee, 2013, Bone Marrow Transplantation.

Topical thalidomide gel in oral chronic GVHD and role of in situ cytokine expression in monitoring biological activity

R. Childs, S. Pavletic, M. Saria, 2013, Bone Marrow Transplantation.

Diagnosis and Treatment of Ocular Chronic Graft-Versus-Host Disease: Report From the German–Austrian–Swiss Consensus Conference on Clinical Practice in Chronic GVHD

A. Heiligenhaus, B. Seitz, H. Greinix, 2012, Cornea.

Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.

C. Loddenkemper, E. Holler, H. Greinix, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

M. Mohty, E. Holler, H. Greinix, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.

S. Hirschfeld, Stephanie J. Lee, M. Flowers, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Szer, B. George, R. Gale, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.

W. Sanger, S. Pavletic, P. Aoun, 2004, Cancer genetics and cytogenetics.

Phase II Clinical Experience with Dose-Adjusted EPOCH-Fludarabine, a Novel Regimen for Targeted Immune Depletion (TID) and Disease Control in Patients with Lymphoid Malignancies Prior to Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RIST).

W. Wilson, S. Steinberg, M. Bishop, 2006 .

Development, preliminary usability and accuracy testing of the EBMT ‘eGVHD App’ to support GvHD assessment according to NIH criteria—a proof of concept

F. Dobbels, S. Geest, H. Greinix, 2016, Bone Marrow Transplantation.

Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.

M. Mayes, G. Kraft, K. Sullivan, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

M. Horowitz, R. Gale, Stephanie J. Lee, 2012, Blood.

A randomized phase-2 trial of pomalidomide in subjects failing prior therapy of chronic graft-versus-host disease.

D. Venzon, R. Gale, W. Figg, 2020, Blood.

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease.

H. Deeg, T. Fleming, J. Dipersio, 2007, Blood.

NCCN Guidelines: Pretransplant Recipient Evaluation and Management of Graft-Versus-Host Disease.

S. Pavletic, C. Cutler, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

A. Barrett, M. Horowitz, J. Wingard, 2009, Blood.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.

S. Pavletic, S. Hashmi, N. Majhail, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Microchimerism in salivary glands after blood- and marrow-derived stem cell transplantation.

S. Pillemer, A. Barrett, B. Baum, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients

E. Cowen, S. Pavletic, F. Hakim, 2022, Journal of Translational Medicine.

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

A. Logan, D. Howard, J. Liesveld, 2021, Blood.

The Future of Chronic Graft-Versus-Host Disease: Introduction to the 2020 National Institutes of Health Consensus Development Project Reports.

Stephanie J. Lee, Paul J. Martin, S. Pavletic, 2021, Transplantation and cellular therapy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report Transplantation and Cellular Therapy

J. Pidala, H. Greinix, V. Bhatt, 2021 .

Rehabilitation interventions in the multi-disciplinary management of patients with sclerotic graft-versus-host disease of the skin and fascia.

B. Solomon, R. Rosenstein, S. Mitchell, 2020, Archives of physical medicine and rehabilitation.

A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703

W. Wood, Bryce Waldman, Z. DeFilipp, 2020 .

Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses.

D. Citrin, K. Baird, E. Cowen, 2011, Archives of dermatology.

The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial

Daniel Wolff, Steffen Fieuws, Carlos Graux, 2018, Haematologica.

Chronic gvhd dictionary—eurograft cost action initiative consensus report

H. Greinix, Stephanie J. Lee, D. Pulanić, 2022, Bone Marrow Transplantation.

Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress

F. Dobbels, H. Greinix, Stephanie J. Lee, 2018, Bone Marrow Transplantation.

Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2016 .

Outcomes of HLA Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative vs. Reduced-Intensity Conditioning Regimens

J. Cortes, M. Aljurf, I. Lewis, 2014 .

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report Transplantation and Cellular Therapy

Shannon R. McCurdy, R. Jenq, R. Lafyatis, 2021 .

Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia.

S. Steinberg, R. Gale, M. Bishop, 2013, Experimental hematology.

Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers.

M. Perales, M. Pasquini, V. Staedtke, 2021, Blood advances.

Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease

J. Pidala, Stephanie J. Lee, M. Flowers, 2015, Haematologica.

transplantation Risk factors for acute GVHD and survival after hematopoietic cell

M. Horowitz, R. Gale, Stephanie J. Lee, 2012 .

HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.

M. Aljurf, B. George, M. Flowers, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Second cancers early post allogeneic transplant: the case of ‘unrestrained’ malignancy?

S. Pittaluga, S. Pavletic, J. Davidson-Moncada, 2013, Bone Marrow Transplantation.

Single-cell Landscape Analysis of the Circulating Human B Cell Pool under Selective Pressure of Allogeneic Stem Cell Transplantation

K. Owzar, Jichun Xie, D. Rizzieri, 2022, bioRxiv.

Comorbidity Burden in Patients with Chronic Graft Versus Host Disease

W. Wood, B. Storer, J. Pidala, 2014 .

Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.

R. Gale, P. Tiberghien, O. Ringdén, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characterization of Hepatic Dysfunction in subjects diagnosed with Chronic GVHD by NIH Consensus Criteria.

D. Kleiner, C. Koh, S. Pavletic, 2022, Transplantation and cellular therapy.

B ational Institutes of Health Consensus Development roject on Criteria for Clinical Trials in Chronic raft-versus-Host Disease : I . Diagnosis and Staging orking Group Report

M. Turner, J. Wingard, Stephanie J. Lee, 2005 .

transplantation superior to HLA-identical siblings for hematopoietic stem cell The graft-versus-leukemia effect using matched unrelated donors is not

J. Wingard, P. McCarthy, S. Spellman, 2011 .

Abnormal liver tests are not sufficient for diagnosis of hepatic graft‐versus‐host disease in critically ill patients

D. Kleiner, E. Wright, C. Koh, 2022, Hepatology communications.

Chronic Graft versus Host Disease: Interdisciplinary Management: Contents

S. Pavletic, G. Vogelsang, 2009 .

Calcinosis Cutis in the Setting of Chronic Skin Graft-Versus-Host Disease.

M. Anadkat, R. Rosenstein, E. Cowen, 2020, JAMA dermatology.

Clinical significance of autoantibodies in a large cohort of patients with chronic graft‐versus‐host disease defined by NIH criteria

S. Steinberg, K. Baird, E. Cowen, 2015, American journal of hematology.

A survey of diagnosis, management, and grading of chronic GVHD.

M. Horowitz, Stephanie J. Lee, M. Flowers, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD

V. Delimar, D. Pulanić, S. Pavletic, 2016, Bone Marrow Transplantation.

Quantitative Salivary Proteomic Differences in Oral Chronic Graft-versus-Host Disease

M. Gucek, K. Baird, J. E. Melvin, 2012, Journal of Clinical Immunology.

Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

H. Greinix, Z. DeFilipp, D. Kelly, 2018, Bone Marrow Transplantation.

Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213)

Stephanie J. Lee, O. Schueller, B. Blazar, 2020, Transplantation and Cellular Therapy.

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2018, Haematologica.

Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant.

G. Illei, J. Segars, A. Decherney, 2009, Fertility and sterility.

Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.

M. Turner, J. Gea-Banacloche, K. Baird, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Single-cell Landscape Analysis of the Human Circulating B Cell Pool under Selective Pressure of Allogeneic Stem Cell Transplantation

K. Owzar, Jichun Xie, D. Rizzieri, 2022, bioRxiv.

Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population

R. Collins, D. Porter, A. Barrett, 2008, Bone Marrow Transplantation.

Chronic graft versus host disease of oral mucosa: review of available therapies.

J. Atkinson, S. Pavletic, J. Brahim, 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.

M. Perales, F. Appelbaum, D. Porter, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

RAPID VISION LOSS ASSOCIATED WITH FLUDARABINE ADMINISTRATION

G. Illei, D. Cunningham, S. Pavletic, 2010, Retina.

Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft‐versus‐host disease

D. Pulanić, S. Pavletic, L. Desnica, 2018, Transfusion.

Early Diagnosis of Labial Fusion in Women After Allogeneic Hematopoietic Cell Transplant Enables Outpatient Treatment

R. Childs, P. Stratton, S. Pavletic, 2017, Journal of lower genital tract disease.

Kahn JM, Brazauskas R, Tecca HR, et al. Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. Blood Adv. 2020;4(9):2084-2094.

M. Norkin, B. George, R. Gale, 2020, Blood advances.

Comorbidity burden in patients with chronic GVHD

W. Wood, B. Storer, J. Pidala, 2013, Bone Marrow Transplantation.

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2011, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Daniel Wolff, Yoshihiro Inamoto, Sandra A Mitchell, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease.

S. Steinberg, A. Im, S. Mitchell, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The isomorphic response in morphealike chronic graft-vs-host disease.

M. Turner, E. Cowen, S. Pavletic, 2008, Archives of dermatology.

Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.

Daniel Wolff, Anita Lawitschka, E. Holler, 2010, Brain : a journal of neurology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Shannon R. McCurdy, R. Jenq, G. Cuvelier, 2021, Transplantation and cellular therapy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.

E. Ramsay, Tianxia Wu, S. Mitchell, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Oral graft-versus-host disease.

I. Alevizos, J. Atkinson, S. Pavletic, 2008, Oral diseases.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

A. Barrett, D. Kleiner, S. Bhatia, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Anita Lawitschka, Stephanie J. Lee, K. Syrjala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease

A. Barrett, K. Csaky, M. Bishop, 2004, Bone Marrow Transplantation.

Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice

S. Steinberg, S. Mitchell, M. Datiles, 2015, Haematologica.

The clinical landscape of chronic graft‐versus‐host disease management in 2021

S. Pavletic, N. Holtzman, 2021, British journal of haematology.

High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease

M. Grce, M. Milošević, D. Pulanić, 2016, Croatian medical journal.

Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease.

S. Steinberg, K. Baird, S. Mitchell, 2015, JAMA dermatology.

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.

S. Rosenberg, J. Gea-Banacloche, S. Feldman, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.

Michael L. Wang, M. Stetler-Stevenson, D. Stroncek, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.

Sadik H. Kassim, W. Telford, S. Rosenberg, 2013, Blood.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

J. Klein, M. Horowitz, J. Wingard, 2014, Clinical Cancer Research.

Measuring Therapeutic Response in Chronic Graft-versus-host-disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus- Host Disease: Iv. Response Criteria Working Group Report

Daniel Wolff, Anita Lawitschka, Sandra A. Mitchell, 2022 .

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Steven Hirschfeld, Lynn H. Gerber, Sandra A. Mitchell, 2006 .

IL-2, the next best thing in chronic GVHD therapy?

S. Pavletic, L. Curtis, 2016, Blood.

Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation.

D. Weisdorf, R. Gingrich, S. Pavletic, 2005, Blood.

Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.

R. Bociek, A. Chanan-Khan, K. Rai, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease

G. Eissner, H. Greinix, D. Pulanić, 2021, Frontiers in Immunology.

Glycolytic metabolism of pathogenic T cells enables early detection of GvHD by 13C-MRI.

W. Linehan, C. Ricketts, S. Pavletic, 2020, Blood.

Fluorescence in situ Hybridization Detection of Cytogenetic Abnormalities in B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

D. Weisenburger, Lynette M. Smith, W. Sanger, 2004, Leukemia & lymphoma.

A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.

R. Srinivasan, M. Bishop, R. Childs, 2009, Blood.

A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display Category : Transplantation Running head : Mining antibody repertoires after transplantation

R. Srinivasan, M. Bishop, R. Childs, 2009 .

Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD

Jennifer Y. Zhang, K. Owzar, Jichun Xie, 2023, bioRxiv.

Hematopoietic Stem Cell Transplantation

A. Im, S. Pavletic, 2020, Abeloff's Clinical Oncology.

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

J. Ritz, D. Miklos, M. V. D. van den Brink, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunotherapy in hematologic malignancies: past, present, and future

A. Im, S. Pavletic, 2017, Journal of Hematology & Oncology.

Single-Cell RNA-Seq Identifies Potentially Pathogenic B Cell Populations That Uniquely Circulate in Patients with Chronic Gvhd

K. Owzar, Jichun Xie, D. Rizzieri, 2019, Blood.

Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.

S. Steinberg, K. Flanders, L. Yao, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

D. Miklos, J. Pidala, E. Russek-Cohen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Assessment of Joint and Fascia Manifestations in Chronic Graft‐Versus‐Host Disease

J. Goldberg, B. Kurland, J. Pidala, 2014, Arthritis & rheumatology.

National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.

J. Shelhamer, S. Steinberg, J. Gea-Banacloche, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT

J. Shelhamer, S. Steinberg, S. Gadalla, 2014, Bone Marrow Transplantation.

Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

M. Gladwin, S. Pavletic, J. Chien, 2009, JAMA.

Correlation of pretransplant and early post‐transplant response assessment with outcomes after reduced‐intensity allogeneic hematopoietic stem cell transplantation for non‐Hodgkin's lymphoma

S. Steinberg, M. Bishop, S. Pollack, 2010, Cancer.

Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants.

O. Ringdén, Tao Wang, M. MacMillan, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Glycolytic metabolism of pathogenic T cells enables early detection of GvHD by 13C-MRI

W. Linehan, C. Ricketts, S. Pavletic, 2020 .

Active thrombopoiesis is associated with worse severity and activity of chronic GVHD

S. Steinberg, A. Barrett, K. Calvo, 2013, Bone Marrow Transplantation.

Von Willebrand Factor and Factor VIII as potential biomarkers of chronic Graft-versus-Host Disease

M. Grce, R. Zadro, D. Pulanić, 2015 .

Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity

S. Steinberg, M. Bishop, K. Baird, 2011, Leukemia.

Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation

M. Bishop, D. Stroncek, S. Pavletic, 2014, Transfusion.

Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation.

S. Steinberg, M. Bishop, S. Pavletic, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

S. Mostafavi, T. Panzarella, M. Aljurf, 2017, Haematologica.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.

M. Mohty, Stephanie J. Lee, S. Pavletic, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic graft-versus-host disease in the era of reduced-intensity conditioning

S. Pavletic, D. Fowler, Deepa S. Subramaniam, 2007, Leukemia.

Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health

P. Herzberg, E. Holler, H. Greinix, 2020, Bone Marrow Transplantation.

High levels of FVIII and von Willebrand factor in chronic Graft-versus-Host Disease

R. Zadro, M. Milošević, D. Pulanić, 2019 .

Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium

B. Kurland, J. Pidala, M. Flowers, 2013, Bone Marrow Transplantation.

Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis.

M. Murad, N. Shah, Stephanie J. Lee, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?

M. Milošević, D. Pulanić, S. Pavletic, 2016, Croatian medical journal.

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD

E. Holler, H. Greinix, S. Pavletic, 2011, Bone Marrow Transplantation.

Deciphering the Mystery: Extracorporeal Photopheresis in Graft-versus-Host Disease.

A. Im, S. Pavletic, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium

B. Kurland, J. Pidala, Stephanie J. Lee, 2011, Haematologica.

Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.

W. Quint, Sarah Wagner, M. Schiffman, 2020, JAMA oncology.

Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation

G. Fahle, A. Nath, A. Freeman, 2013, Neurology.

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

S. Steinberg, M. Sabatino, B. Levine, 2013, Blood.

Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation.

S. Steinberg, S. Pittaluga, M. Bishop, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

P. Bierman, E. Montserrat, K. Ballen, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses

S. Steinberg, A. Fojo, B. Levine, 2015, Clinical Cancer Research.

Nonmyeloablative allogeneic hematopoietic stem cell transplantation for autoimmune disease.

S. Pavletic, 2004, Arthritis and rheumatism.

Transplantation for SLE

S. Pavletic, 2005 .

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results

G. Kraft, R. Storb, J. Bowen, 2011, Bone Marrow Transplantation.

Outcomes of human leukocyte antigen-matched sibling donor hematopoietic cell transplantation in chronic lymphocytic leukemia: myeloablative versus reduced-intensity conditioning regimens.

J. Cortes, M. Aljurf, I. Lewis, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease

R. Zadro, M. Milošević, D. Pulanić, 2021, Croatian medical journal.

Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease

B. Storer, J. Pidala, Stephanie J. Lee, 2014, Haematologica.

Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD

W. Wood, J. Pidala, Stephanie J. Lee, 2014, Bone Marrow Transplantation.

Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study

B. Kurland, J. Pidala, M. Arora, 2013, Leukemia.

Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Haematologica.

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

J. Gribben, E. Montserrat, F. Awan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prior rituximab correlates with less acute graft‐versus‐host disease and better survival in B‐cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation

R. Gale, H. Khoury, O. Ringdén, 2009, British journal of haematology.

A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease

A. Sirajuddin, S. Pavletic, S. Agbor-Enoh, 2022, Blood advances.

An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.

K. Owzar, Corbin D. Jones, J. Serody, 2017, Blood.

Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease

S. Davis, W. Telford, D. Stroncek, 2016, The Journal of Immunology.

Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease.

S. Steinberg, K. Baird, M. Datiles, 2011, Blood.

burden of disease Sclerotic-type chronic GVHD of the skin : clinical risk factors , laboratory

S. Steinberg, K. Baird, S. Mitchell, 2011 .

Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.

P. Brooks, P. Emery, J. Snowden, 2004, The Journal of rheumatology.

Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience.

C. Haire, L. Klassen, A. Kessinger, 2001, The Journal of rheumatology. Supplement.

Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

N. Kröger, D. Porter, C. June, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Young Man with Lymphocytosis

B. Djulbegovic, S. Pavletic, F. Hendler, 1999 .

Rippled skin, fasciitis, and joint contractures.

L. Yao, H. Malech, E. Cowen, 2008, Journal of the American Academy of Dermatology.

Prognostic factors influencing survival in patients with B‐cell small lymphocytic lymphoma

D. Weisenburger, J. Armitage, Lynette M. Smith, 2004, American journal of hematology/oncology.

A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

Li Li, Sandra A Mitchell, Kristin Baird, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Feasibility and Reproducibility of the NIH Consensus Criteria To Evaluate Response in Chronic Graft Versus Host Disease (cGvHD).

B. Reeve, M. Turner, K. Baird, 2006 .

Clinical benefit of response in chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Blood.

Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters

D. Pulanić, S. Pavletic, L. Desnica, 2016, Croatian medical journal.

Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?

G. Basak, D. Pulanić, S. Pavletic, 2016, Croatian medical journal.

J. Varni, H. Greinix, S. Pavletic, 2014, Bone Marrow Transplantation.

Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.

J. Pidala, Stephanie J. Lee, D. Weisdorf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor with a CD28 Costimulatory Moiety Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Michael L. Wang, M. Stetler-Stevenson, D. Stroncek, 2017 .

CD69+ resident memory T cells are associated with graft‐versus‐host disease in intestinal transplantation

M. Zasloff, T. Fishbein, S. Robson, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Syk and tired of current chronic GVHD therapies.

S. Pavletic, D. Fowler, 2015, Blood.

Treatment of high-risk chronic GVHD.

S. Pavletic, Georgia B Vogelsand, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia.

J. Pidala, Stephanie J. Lee, M. Flowers, 2020, Blood advances.

Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for Reducing Chronic Graft-Versus-Host Disease After Haploidentical Transplantation: Just Another Labor-Intensive Strategy, or Showing the Way?

H. Lazarus, S. Pavletic, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of measurement scales in ocular graft-versus-host disease.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Ophthalmology.

Chronic Graft versus Host Disease: Interdisciplinary Management: Plate section

S. Pavletic, G. Vogelsang, 2009 .

Chronic Graft versus Host Disease: Interdisciplinary Management: Diagnosis and Staging

S. Pavletic, A. Filipovich, M. Jagasia, 2009 .

Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.

A. Barrett, T. Fry, J. Tisdale, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally

S. Pavletic, S. Hashmi, K. Cooke, 2018, Bone Marrow Transplantation.

Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease

J. Shelhamer, Stephanie J. Lee, J. Gea-Banacloche, 2013 .

Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials

Z. DeFilipp, Stephanie J. Lee, B. Blazar, 2022, Blood advances.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, J. Klein, 2015, Biology of Blood and Marrow Transplantation.

Abstracts from Scientific Programme

P. Lipsky, J. Gea-Banacloche, P. Muraro, 2010, Bone Marrow Transplantation.

S. Pavletic, C. Allen, A. McBride, 2021, Clinical case reports.

Allogeneic hematopoietic cell transplant for prolymphocytic leukemia.

J. Cortes, J. Szer, M. Horowitz, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Durable discontinuation of systemic therapy for chronic graft-versus-host disease: myth or reality?

S. Pavletic, K. Schultz, 2022, Haematologica.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

J. Klein, M. Horowitz, J. Wingard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.

A. Bacigalupo, S. Pavletic, G. Barisione, 2012, Seminars in hematology.

Gastrointestinal Complications of Hematopoietic Cell Transplantation

S. Pavletic, T. Heller, N. Samala, 2013 .

Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate

K. Baird, S. Mitchell, E. Cowen, 2019, Supportive Care in Cancer.

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.

H. Deeg, D. Porter, J. Cortes, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Trends In Incidence, Presentation, and Outcomes Of Chronic Graft-Versus-Host Disease In Allogeneic Transplantation- Report From The Center For International Blood and Marrow Transplant Research

S. Spellman, Tao Wang, M. Arora, 2013 .

Granulocytic invasion of the central nervous system after hematopoietic stem cell transplantation for systemic lupus erythematosus.

P. Lipsky, G. Illei, J. Butman, 2006, Haematologica.

Discordant functional and inflammatory parameters in multiple sclerosis patients after autologous haematopoietic stem cell transplantation

C. Enke, M. Filipi, J. Bowen, 2004, Multiple sclerosis.

Considerations when designing a clinical trial of haematopoietic stem cell transplantation for autoimmune disease.

C. Bredeson, S. Pavletic, 2004, Best practice & research. Clinical haematology.

Elevated BAFF Is Correlated with Inflammatory Processes in Chronic Graft Versus Host Disease and Supports Increases in Transitional B Cells

E. Cowen, S. Pavletic, R. Gress, 2008 .

Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.

D. Mollura, U. Bagci, Brent Foster, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

No adverse effect of ABVD chemotherapy in a patient with chronic hepatitis C and Hodgkin’s disease

S. Pavletic, Vladimir Stančić, I. Grgurević, 2004, Wiener klinische Wochenschrift.

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

H. Atkins, M. Sormani, M. Freedman, 2017, JAMA neurology.

Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.

B. Sandmaier, D. Porter, K. Ballen, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Development of severe sclerotic chronic GVHD during treatment with dasatinib

M. Bishop, K. Baird, D. Pulanić, 2010, Bone Marrow Transplantation.

Vitamin D levels and their associations with survival and major disease outcomes in a large cohort of patients with chronic graft-vs-host disease

S. Steinberg, D. Pulanić, S. Pavletic, 2016, Croatian medical journal.

aGVHDAI: escape from the silo

S. Pavletic, 2006 .

Distinct MYC thresholds in hematopoietic neoplasia Enforced transgenic expression of c-MYC causes monocytic neoplasms in heterozygous transgenic mice but T-cell lymphomas in homozygous transgenic mice, demonstrating that tuned thresholds of induce neoplastic

S. Pavletic, 2006 .

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

W. Wood, J. Pidala, Yi-Bin Chen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Characterization and Cytokine Profile of Fatigue in Hematologic Malignancy Patients with Chronic Graft-Versus-Host Disease

S. Steinberg, A. Im, L. Saligan, 2021, Bone Marrow Transplantation.

CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: comment on the article by Moore et al.

J. V. van Laar, S. Pavletic, 2003, Arthritis and rheumatism.

Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid arthritis.

J. O'dell, C. Haire, L. Klassen, 2001, The Journal of rheumatology. Supplement.

Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)

N. Leidy, K. Mooney, P. Palit, 2010, Bone Marrow Transplantation.

Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease.

S. Steinberg, L. Morton, E. Cowen, 2021, Transplantation and cellular therapy.

Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus

S. Pavletic, T. Heller, A. Ling, 2017, Mayo Clinic proceedings. Innovations, quality & outcomes.

Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients.

S. Steinberg, A. Im, K. Baird, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease

D. Vitali Čepo, D. Pulanić, S. Pavletic, 2020, Journal of Cancer Research and Clinical Oncology.

Target populations in allogeneic hematopoietic cell transplantation for autoimmune diseases--a workshop accompanying: cellular therapy for treatment of autoimmune diseases, basic science and clinical studies, including new developments in hematopoietic and mesenchymal stem cell therapy.

D. Furst, A. Gratwohl, A. Tyndall, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quantitative Salivary Proteomic Differences in Oral Chronic Graft-versus-Host Disease

Marjan Gucek, James E. Melvin, Kristin Baird, 2012, Journal of Clinical Immunology.

The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease

A. Sirajuddin, S. Pavletic, S. Agbor-Enoh, 2022, Blood Advances.

Measurement of Oral Chronic Graft-Versus-Host Disease

B. Kurland, J. Pidala, M. Flowers, 2012 .

B. Kurland, M. Flowers, M. Arora, 2012 .

Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD

S. Steinberg, A. Im, K. Baird, 2016, Bone Marrow Transplantation.

Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease.

L. Yao, M. Turner, S. Mitchell, 2009, Archives of dermatology.

Feasibility and Reproducibility of the New NIH Consensus Criteria To Evaluate Response in Chronic GvHD - A Pilot Study.

B. Reeve, M. Turner, S. Mitchell, 2005 .

Spiritual well-being in long-term survivors with chronic graft-versus-host disease after hematopoietic stem cell transplantation.

S. Steinberg, A. Berger, S. Mitchell, 2010, The journal of supportive oncology.

Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes

S. Pavletic, Y. Migdady, J. Sabile, 2023, Cancer journal.

Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)

A. Im, S. Pavletic, Maureen R. Bleam, 2019, Blood.

Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective

S. Pavletic, D. Fowler, S. Bramanti, 2023, Frontiers in Immunology.

Quality of Life in Patients With Skin of Color and Chronic Graft-vs-Host Disease.

Srikanta Banerjee, R. Rosenstein, E. Cowen, 2020, JAMA dermatology.

Clinical significance of IgE in a large cohort of patients with moderate or severe chronic graft‐versus‐host disease

S. Steinberg, E. Cowen, S. Pavletic, 2017, American journal of hematology.

T Cells Expressing a Novel Fully-Human Anti-CD19 Chimeric Antigen Receptor Induce Remissions of Advanced Lymphoma in a First-in-Humans Clinical Trial

S. Pittaluga, M. Bagheri, D. Stroncek, 2016 .

"Regulating" rheumatoid arthritis via autotransplantation.

S. Pavletic, D. Fowler, Daniel H. Fowler, 2008, Blood.

Immunogenicity of HPV Quadrivalent Vaccine in Women after Allogeneic HCT is Comparable to Healthy Volunteers

A. Barrett, J. Tisdale, R. Childs, 2018 .

Development and Preliminary Usability and Accuracy Testing of the EBMT Gvhd App to Support Graft Versus Host Disease Diagnosis and Scoring According to NIH Criteria, By the EBMT Complications and Quality of Life Working Party

F. Dobbels, S. Geest, H. Greinix, 2015 .

Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes

S. Pavletic, S. Freeman, P. Aplan, 2023, Blood advances.

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD

J. Ritz, Stephanie J. Lee, S. Paczesny, 2022, Blood advances.

Accompanying editorial on paper Neutrophil Extracellular Traps (NETs) contribute to Pathological Changes of ocular Graft-vs.-Host Disease (oGVHD) Dry Eye: Implications for novel Biomarkers and Therapeutic Strategies by Seungwon An et al.

S. Pavletic, I. Petriček, 2019, The ocular surface.

Long-term follow-up after lymphodepleting autologous hematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.

S. Steinberg, P. Lipsky, G. Illei, 2021, Rheumatology.

Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease.

S. Steinberg, S. Mitchell, E. Cowen, 2023, Haematologica.

Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease.

J. Yanovski, E. Cowen, S. Pavletic, 2023, Bone marrow transplantation.

Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease

S. Steinberg, E. Cowen, S. Pavletic, 2023, Bone Marrow Transplantation.

Efficacy and Safety of Baricitinib in Refractory Chronic Graft-Versus-Host Disease (cGVHD): Preliminary Analysis Results of a Phase 1/2 Study

W. Figg, A. Im, C. Peer, 2020 .

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

S. Steinberg, M. Sabatino, B. Levine, 2013, Blood.

A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.

R. Srinivasan, M. Bishop, R. Childs, 2009, Blood.

Immunotherapy for acute leukemia

T. Whiteside, M. Boyiadzis, S. Pavletic, 2015, Aging.

Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally

S. Pavletic, S. Hashmi, K. Cooke, 2018, Bone Marrow Transplantation.

Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease

S. Pavletic, Daniel Martin, F. Hakim, 2021, iScience.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.

J. Pidala, M. Flowers, S. Pavletic, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

M. Horowitz, J. Wingard, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.

S. Steinberg, K. Flanders, L. Yao, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.

Stephanie J. Lee, S. Pavletic, K. Schultz, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

45: Development of Antibodies to Self Antigens K-alpha-1 Tubulin and Collagen V in Patients with Chronic Graft Versus Host Disease

W. Shannon, J. Dipersio, T. Mohanakumar, 2008 .

Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa.

W. Swaim, S. Pavletic, R. Gress, 2009, Blood.

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses

S. Steinberg, A. Fojo, B. Levine, 2015, Clinical Cancer Research.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, D. Maloney, 2015, Biology of Blood and Marrow Transplantation.

Association Of Graft Vs. Host Disease (GVHD) With a Lower Relapse/Progression Rate After Allogeneic Hemopoietic Stem Cell Transplantation (HSCT) With Reduced Intentsity Conditioning In Patients With Follicular and Mantle Cell Lymphoma: A Cibmtr Analysis

S. Montoto, Sonali M. Smith, D. Maloney, 2013 .

Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR

M. Horowitz, R. Gale, Stephanie J. Lee, 2010 .

Chronic Graft versus Host Disease: Interdisciplinary Management: Contents

S. Pavletic, K. Atkinson, G. Vogelsang, 2009 .

Subsequent neoplasms and late mortality in children undergoing Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases allogeneic transplantation for nonmalignant diseases

M. Norkin, B. Alter, M. Flowers, 2022 .

Syk and tired of current chronic GVHD therapies.

S. Pavletic, D. Fowler, 2015, Blood.

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

W. Wood, J. Pidala, Yi-Bin Chen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.